Prime Medicine
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Prime Medicine generated cash of -$165,412,000, which is less than the previous year. Cash used in financing activities reached the amount of $655,000 last year. Net change in cash is therefore -$146,046,000.
Cash Flow
| 2019 | -1.33M | 0 | 9.98M |
|---|---|---|---|
| 2020 | -5.54M | -1.06M | 34.93M |
| 2021 | -34.08M | -73.62M | 269.27M |
| 2022 | -131.82M | -47.09M | 181.49M |
| 2023 | -165.41M | 18.71M | 655K |
PRME Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 201.11M | 198.54M | 36.97M | 8.64M | 0 |
Operating activities | |||||
Net income | -198.13M | -121.82M | -165.36M | -3.41M | -2.52M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 4.65M | 2.22M | 568K | 43K | 0 |
Stock-based compensation expense | 13.91M | 6.45M | 1.74M | 391K | 0 |
| Deferred income tax benefit | 13.91M | 6.45M | 1.74M | 391K | 0 |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 9.14M | 2.45M | 1.18M | 250K | 0 |
Cash generated by operating activities | -165.41M | -131.82M | -34.08M | -5.54M | -1.33M |
Investing activities | |||||
Purchases Of Investments | -104.95M | -123.33M | -81.98M | 0 | 0 |
Investments In Property Plant And Equipment | -8.72M | -16.09M | -4.15M | -639K | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 18.71M | -47.09M | -73.62M | -1.06M | 0 |
Financing activities | |||||
Common Stock Issued | 655K | 185.31M | 270.36M | 34.95M | 9.98M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 655K | 181.49M | 269.27M | 34.93M | 9.98M |
Net Change In Cash | -146.04M | 2.57M | 161.57M | 28.32M | 8.64M |
Cash at end of period | 55.07M | 201.11M | 198.54M | 36.97M | 8.64M |
| Data source | Data source |